ReviewJournal of blood medicine2016
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.
Johanna Mondesir et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
121 papers cite itlatest 60 shown
this papertrialcites it